GH
Guardant Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$179.38
−2.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 15.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -108.01x
- Price / sales
- 20.35x
- Price / cash flow
- -129.99x
Enterprise value
- Enterprise value
- $24.7B
- EV / sales
- 20.89x
- EV / EBITDA
- -60.11x
- EV / EBIT
- -52.56x
- Market cap
- $24.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026